BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27995731)

  • 1. Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study.
    Radhakutty A; Stranks JL; Mangelsdorf BL; Drake SM; Roberts GW; Zimmermann AT; Stranks SN; Thompson CH; Burt MG
    Diabetes Obes Metab; 2017 Apr; 19(4):571-578. PubMed ID: 27995731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.
    Ruiz de Adana MS; Colomo N; Maldonado-Araque C; Fontalba MI; Linares F; García-Torres F; Fernández R; Bautista C; Olveira G; de la Cruz JL; Rojo-Martínez G; Valdés S
    Diabetes Res Clin Pract; 2015 Nov; 110(2):158-65. PubMed ID: 26474657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a basal bolus insulin protocol to treat prednisolone-induced hyperglycaemia in hospitalised patients.
    Burt MG; Drake SM; Aguilar-Loza NR; Esterman A; Stranks SN; Roberts GW
    Intern Med J; 2015 Mar; 45(3):261-6. PubMed ID: 25565560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of weight-based insulin glargine dose titration regimen compared with glucose level- and current dose-based regimens in hospitalized patients with type 2 diabetes: a randomized, controlled study.
    Li X; Du T; Li W; Zhang T; Liu H; Xiong Y
    Clin Ther; 2014 Sep; 36(9):1269-75. PubMed ID: 25062651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy.
    Jendle J; Testa MA; Martin S; Jiang H; Milicevic Z
    Diabetes Obes Metab; 2016 Oct; 18(10):999-1005. PubMed ID: 27279266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
    Choudhary P; Davies C; Emery CJ; Heller SR
    Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes.
    Vellanki P; Bean R; Oyedokun FA; Pasquel FJ; Smiley D; Farrokhi F; Newton C; Peng L; Umpierrez GE
    Diabetes Care; 2015 Apr; 38(4):568-74. PubMed ID: 25665812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections.
    Li FF; Fu LY; Zhang WL; Su XF; Wu JD; Sun J; Ye L; Ma JH
    J Diabetes Res; 2016; 2016():1028945. PubMed ID: 26839889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
    Yeldandi RR; Lurie A; Baldwin D
    Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief report: Comparison of continuous glucose monitoring and finger-prick blood glucose levels in hospitalized patients administered basal-bolus insulin.
    Burt MG; Roberts GW; Aguilar-Loza NR; Stranks SN
    Diabetes Technol Ther; 2013 Mar; 15(3):241-5. PubMed ID: 23360391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial.
    Zhang T; Lin M; Li W; Fan X; Du T; Zhao Y; Zhang X
    Adv Ther; 2016 Feb; 33(2):178-85. PubMed ID: 26809253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
    Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
    Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.
    Bellido V; Suarez L; Rodriguez MG; Sanchez C; Dieguez M; Riestra M; Casal F; Delgado E; Menendez E; Umpierrez GE
    Diabetes Care; 2015 Dec; 38(12):2211-6. PubMed ID: 26459273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring.
    Pettus J; Gill J; Paranjape S; Stewart J; Malla S; Edelman S; Bergenstal RM; Bode B
    Diabetes Obes Metab; 2019 Aug; 21(8):1906-1913. PubMed ID: 30993855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes.
    Aberer F; Lichtenegger KM; Smajic E; Donsa K; Malle O; Samonigg J; Höll B; Beck P; Pieber TR; Plank J; Mader JK
    Diabetes Obes Metab; 2019 Mar; 21(3):584-591. PubMed ID: 30328252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes.
    Turner D; Luzio S; Gray BJ; Bain SC; Hanley S; Richards A; Rhydderch DC; Martin R; Campbell MD; Kilduff LP; West DJ; Bracken RM
    Diabet Med; 2016 Apr; 33(4):506-10. PubMed ID: 26220149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial.
    Vellanki P; Rasouli N; Baldwin D; Alexanian S; Anzola I; Urrutia M; Cardona S; Peng L; Pasquel FJ; Umpierrez GE;
    Diabetes Obes Metab; 2019 Apr; 21(4):837-843. PubMed ID: 30456796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison on the efficacy of biphasic insulin aspart 30 and premixed human insulin 30/70 through continuous glucose monitoring system].
    Chen SF; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Aug; 32(8):827-9. PubMed ID: 22093477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from glargine+insulin aspart to glargine+insulin aspart 30 before breakfast combined with exercise after dinner and dividing meals for the treatment of type 2 diabetes patients with poor glucose control - a prospective cohort study.
    Li J; Wang L; Chen F; Xia D; Miao L
    BMC Endocr Disord; 2018 Oct; 18(1):69. PubMed ID: 30285711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed insulin can improve control of prednisolone-induced hyperglycaemia.
    Scholes G; Ng E; Bach LA; Sztal-Mazer S
    Intern Med J; 2023 Dec; 53(12):2264-2269. PubMed ID: 36880383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.